NET Patient Foundation Inc » Pharmaceutical Studies http://www.netpatientfoundation.com Help and support for those with the Quiet Cancer Thu, 10 Jun 2010 12:53:17 +0000 http://wordpress.org/?v=2.8.4 en hourly 1 Current Pharmaceutical Clinical Trials http://www.netpatientfoundation.com/research-for-nets/ http://www.netpatientfoundation.com/research-for-nets/#comments Wed, 16 Jul 2008 15:13:28 +0000 admin http://www.netpatientfoundation.com/?p=349 Listed here are some of the clinical trials being conducted at present. If you’re interested in taking part in a clinical trial, speak to your NET specialist nurse or doctor.

Efficacy and Safety of Everolimus (RAD001) in Female or Male Patients 18 Years of Older with Advanced Neuroendocrine Tumors

Sponsored by Novartis

This study is ongoing, but not recruiting participants.

RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-Endocrine Tumors in Europe (RAMSETE/CDE16)

Sponsored by Novartis

This study is not yet open for participant recruitment

Safety and Efficacy of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

Sponsored by Novartis

This study is currently recruiting participants

Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor

Sponsored by Novartis

This study is ongoing, but not recruiting participants

SOM clinical trial details — carcinoid C2303 page 1 pdf.zip

SOM clinical trial details — carcinoid C2303 page 2 pdf.zip

FINAL – Sandostatin LAR – US ASCO GI press release – January 13 2009>>

]]> http://www.netpatientfoundation.com/research-for-nets/feed/ 0